164 related articles for article (PubMed ID: 19965777)
1. L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation.
Buga GM; Navab M; Imaizumi S; Reddy ST; Yekta B; Hough G; Chanslor S; Anantharamaiah GM; Fogelman AM
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):283-9. PubMed ID: 19965777
[TBL] [Abstract][Full Text] [Related]
2. Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats.
Deng ZY; Shan WG; Wang SF; Hu MM; Chen Y
Pharm Biol; 2017 Dec; 55(1):663-672. PubMed ID: 27951728
[TBL] [Abstract][Full Text] [Related]
3. A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
Navab M; Ruchala P; Waring AJ; Lehrer RI; Hama S; Hough G; Palgunachari MN; Anantharamaiah GM; Fogelman AM
J Lipid Res; 2009 Aug; 50(8):1538-47. PubMed ID: 19225094
[TBL] [Abstract][Full Text] [Related]
4. Differential Impact In Vivo of Pf4-ΔCre-Mediated and Gp1ba-ΔCre-Mediated Depletion of Cyclooxygenase-1 in Platelets in Mice.
Tang SY; Lordan R; Meng H; Auerbach BJ; Hennessy EJ; Sengupta A; Das US; Joshi R; Marcos-Contreras OA; McConnell R; Grant GR; Ricciotti E; Muzykantov VR; Grosser T; Weiljie AM; FitzGerald GA
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1393-1406. PubMed ID: 38660804
[TBL] [Abstract][Full Text] [Related]
5. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.
Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Handattu SP; Mishra VK; Anantharamaiah GM
Atherosclerosis; 2012 Oct; 224(2):326-31. PubMed ID: 22771190
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
[TBL] [Abstract][Full Text] [Related]
8. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
[TBL] [Abstract][Full Text] [Related]
9. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
[TBL] [Abstract][Full Text] [Related]
10. Platelet function in Watanabe heritable hyperlipidemic rabbits. Decreased sensitivity to thromboxane A2.
Gross PL; Rand ML; Barrow DV; Packham MA
Arterioscler Thromb; 1991; 11(3):610-6. PubMed ID: 2029501
[TBL] [Abstract][Full Text] [Related]
11. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
12. L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.
Imaizumi S; Grijalva V; Navab M; Van Lenten BJ; Wagner AC; Anantharamiah GM; Fogelman AM; Reddy ST
Drug Metab Lett; 2010 Aug; 4(3):139-48. PubMed ID: 20642447
[TBL] [Abstract][Full Text] [Related]
13. D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet.
Buga GM; Frank JS; Mottino GA; Hendizadeh M; Hakhamian A; Tillisch JH; Reddy ST; Navab M; Anantharamaiah GM; Ignarro LJ; Fogelman AM
J Lipid Res; 2006 Oct; 47(10):2148-60. PubMed ID: 16835442
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet effect of NQ12: a possible mechanism through the arachidonic acid cascade.
Jin YR; Han XH; Lee JJ; Lim Y; Kim TJ; Yoo HS; Hong JT; Lee CK; Yun YP
J Pharmacol Sci; 2007 Oct; 105(2):193-200. PubMed ID: 17951980
[TBL] [Abstract][Full Text] [Related]
15. Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma.
Meriwether D; Imaizumi S; Grijalva V; Hough G; Vakili L; Anantharamaiah GM; Farias-Eisner R; Navab M; Fogelman AM; Reddy ST; Shechter I
J Lipid Res; 2011 Oct; 52(10):1795-809. PubMed ID: 21804067
[TBL] [Abstract][Full Text] [Related]
16. Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity.
Gaudette DC; Holub BJ
Lipids; 1990 Mar; 25(3):166-9. PubMed ID: 2139712
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.
Morgantini C; Imaizumi S; Grijalva V; Navab M; Fogelman AM; Reddy ST
Diabetes; 2010 Dec; 59(12):3223-8. PubMed ID: 20826564
[TBL] [Abstract][Full Text] [Related]
18. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
[TBL] [Abstract][Full Text] [Related]
19. Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.
Woo JM; Lin Z; Navab M; Van Dyck C; Trejo-Lopez Y; Woo KM; Li H; Castellani LW; Wang X; Iikuni N; Rullo OJ; Wu H; La Cava A; Fogelman AM; Lusis AJ; Tsao BP
Arthritis Res Ther; 2010; 12(3):R93. PubMed ID: 20482780
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion.
Riddell DR; Owen JS
Thromb Res; 1996 Mar; 81(5):597-606. PubMed ID: 9054055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
